Up to 95% of pancreatic tumours contain a KRAS mutation, the majority of which involve a mutation in codon 12 (Bournet et al. 2016; Buscail et al. 2020; Waters and Der 2018). The gene discussed is KRAS; the disease is pancreatic neoplasm.